Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.

<h4>Background</h4>Uganda recently adopted artemether-lumefantrine (AL) as the recommended first-line treatment for uncomplicated malaria. However, AL has several limitations, including a twice-daily dosing regimen, recommendation for administration with fatty food, and a high risk of reinfection so...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Adoke Yeka, Grant Dorsey, Moses R Kamya, Ambrose Talisuna, Myers Lugemwa, John Bosco Rwakimari, Sarah G Staedke, Philip J Rosenthal, Fred Wabwire-Mangen, Hasifa Bukirwa
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Public Library of Science (PLoS) 2008-06-01
Serie:	PLoS ONE
Accesso online:	https://escholarship.org/uc/item/0dh8831z
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!